Rudi M. Marien

Besides being co-founder, majority shareholder and Chairman of Innogenetics, Rudi Mariën (Belgium) is also the founder, shareholder and Managing Director of several clinical reference laboratories. He holds additional board positions in different stock-listed and private biotech companies. Rudi was the founder, shareholder and Managing Director of the Barc Group, a leading international centralized clinical laboratory, exclusively dedicated to pharmaceutical studies. Currently he is Vice President of Cerba European Lab (European network of medical labs) and President & Managing Director of Gengest Bvba and Biovest CVA. Through his management company, Gengest BVBA, Rudi also holds board positions in different stock-listed and private biotech companies. Rudi holds a degree in pharmaceutical sciences from the University of Gent and is specialized in clinical biology.